Multiple cell-surface receptors on local tissue and immune cells

The term Multiple cell-surface receptors on local tissue and immune cells refers to a broad and heterogeneous collection of membrane-bound proteins rather than a single molecular entity. This designation is frequently used in pharmacological contexts, particularly in the labeling of interferons and other pleiotropic cytokines, to describe their wide-ranging effects across various cell types (NCBI, StatPearls). These receptors, which include members of the cytokine receptor superfamily and G protein-coupled receptors, serve as the primary interface for extracellular ligands to trigger essential biological processes such as the antiviral response, immune modulation, and growth regulation (PubMed, PMID: 11252230). In disease states like chronic viral hepatitis or various malignancies, drugs targeting these multiple receptors aim to enhance the host's immune surveillance and inhibit cellular proliferation (FDA, Label for Intron A). However, because this 'target' is non-specific and encompasses receptors found on nearly all nucleated cells, therapeutic intervention often leads to significant systemic side effects and complex safety profiles. Consequently, while biologically significant, this term is considered a descriptive category of action rather than a specific, individual therapeutic target.

Other names

Cell surface receptorsImmune cell receptorsTissue-specific receptorsCytokine receptors

Binding to and modulating multiple distinct cell-surface receptors to initiate intracellular signaling cascades, such as the JAK-STAT pathway, to elicit systemic biological responses.